In response to EMA's upcoming announcement regarding EMA CDP Policy 0070 Step 2 Relaunch, we are hosting a webinar on Thursday, November 21st at 9am EST. You can learn more and register here.
Also on Thursday, November 21st, starting at 11:00am EST we will present: Best Practices for Clinical Data Anonymization Using the Quantitative Methodology. Learn more and register here.
RLS PROTECT is the leading data and document anonymization and redaction solution designed specifically for Sponsors and CROs who comply with transparency requirements for regulatory bodies and voluntary sharing initiatives. RLS PROTECT offers the most advanced quantitative risk modeling, document anonymization and redaction capabilities enabling your organization to scale and support the increasing demands of Health Canada PRCI, EMA Policy 0070, EMA (EU) 536/2014, FDA as well as data sharing partners supporting secondary research.
Visit our European Medicines Agency (EMA) CTR & CTIS Pages:
European Medicines Agency (EMA) Clinical Trial Regulation (CTR) Overview
European Medicines Agency (EMA) Clinical Trials Information System (CTIS) Overview